August 2023 in “Annales de Dermatologie et de Vénéréologie” This review analyzed data from 237 patients across 27 publications to provide an updated overview of non-scarring alopecia (NSA) in lupus erythematosus (LE) patients. It found that diffuse/patchy NSA and lupus hair are strongly associated with systemic LE activity, show subtle signs of inflammation, and typically respond well to SLE therapy without progressing to scarring alopecia. In contrast, NSA associated with dermal cutaneous LE or lupus panniculitis of the scalp is less commonly linked to SLE and responds better to skin-directed therapies. The study suggests that diffuse/patchy NSA and lupus hair may be variations of a single LE-specific entity and calls for prospective studies to further explore this manifestation.
1 citations,
June 2021 in “Curēus” A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.
15 citations,
February 2017 in “Nursing Clinics of North America” Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.
17 citations,
October 2003 in “Contact dermatitis” Glycerin in hand cream can cause allergic skin reactions.
284 citations,
November 1999 in “Neurology” The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.